CORE--TISSUE CULTURE AND MONOCLONAL ANTIBODIES

$256,972P30FY2000HDNIH

University Of Kansas Lawrence, Lawrence KS

Investigators

Linked publications & trials

Paper 37100111 Paper 36788028 Paper 36674736 Paper 36515769 Paper 36190479 Paper 36189118 Paper 36092249 Paper 35918752 Paper 35903967 Paper 35596532 Paper 35559809 Paper 35400984 Paper 35295799 Paper 35186383 Paper 34773373 Paper 34153191 Paper 34046054 Paper 33562221 Paper 33503544 Paper 33399417 Paper 33281438 Paper 32662379 Paper 32463706 Paper 32407290 Paper 32132879 Paper 32130865 Paper 31714169 Paper 31587679 Paper 31568043 Paper 31527255 Paper 31487475 Paper 31331040 Paper 31221730 Paper 31184217 Paper 31161414 Paper 31061749 Paper 30866437 Paper 30715926 Paper 30637262 Paper 30569567 Paper 30556641 Paper 30556062 Paper 30311214 Paper 30289596 Paper 30197548 Paper 30150363 Paper 29971356 Paper 29893787 Paper 29651972 Paper 29636407 Paper 29522838 Paper 29494490 Paper 29476821 Paper 29464752 Paper 29459141 Paper 29437285 Paper 29415681 Paper 29379420 Paper 29360733 Paper 29273483 Paper 29255901 Paper 29246791 Paper 29198900 Paper 29185921 Paper 29178241 Paper 29155208 Paper 29129958 Paper 29052841 Paper 29040924 Paper 29032150 Paper 28994181 Paper 28984907 Paper 28966709 Paper 28930237 Paper 28760966 Paper 28726285 Paper 28690488 Paper 28682308 Paper 28643872 Paper 28550261 Paper 28523532 Paper 28474384 Paper 28474087 Paper 28419188 Paper 28387067 Paper 28344932 Paper 28265775 Paper 28264500 Paper 28257530 Paper 28239983 Paper 28219082 Paper 28163819 Paper 28163818 Paper 28155818 Paper 28142500 Paper 28114610 Paper 28111641 Paper 28074357 Paper 28062309 Paper 28036410

Abstract

The goals for the Tissue Culture and Monoclonal Antibody (TCMA) Laboratory remain as outlined in the original proposal for this Core facility: 1. To maintain a cost-effective centralized facility where cell culture and monoclonal antibody/hybridoma-related activities can be performed by and for investigators at the lawrence and the Medical Center settings of the MRDDRG. 2. To assist investigators in the growth and maintenance of primary cell cultures and cell lines used in a variety of molecular and cellular studies. 3. To carry out generation and characterization of monoclonal antibodies for MRDDRC investigators and maintain hybridoma cell lines for the investigators whose research programs require a consistent supply of antibodies. 4. To provide fluorescence activated flow cytometry capabilities for analysis of specific cell phenotypes and the effects of various experimental treatments.

View original record on NIH RePORTER →